Autotransfusion Devices Market Size, Share | Analysis - 2028

Autotransfusion Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Product and Accessories); Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Others); End User (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers)

  • Report Code : TIPRE00006521
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 178

Autotransfusion Devices Market Size, Share | Analysis - 2028

Buy Now

The autotransfusion devices market is expected to grow from US$ 1,000.26 million in 2021 to US$ 1,331.99 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028.

Organ transplantation is a surgical procedure performed in case of organ failure. Usually, organ transplantation is conducted for organs such as the heart, liver, and kidney; however, with rising cases of chronic diseases, transplantation is needed for other organs such as lungs, pancreas, cornea, and vascular tissues. These procedures generally take hours, and there is a lot of blood loss, and autotransfusion is one of the valuable methods to prevent blood loss. According to the United Network for Organ Sharing (UNOS), organ transplants conducted in the US have continuously increased, with over 41,000 transplants performed in 2021. Similarly, according to World Transplant Registry data, Spain accounted for 20% of all organ donations in the EU in 2019 and 6% of worldwide donations. Australia's organ donor rate has improved in recent years, rising to 21.8 donors per million population in 2019.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Autotransfusion Devices Market: Strategic Insights

Autotransfusion Devices Market
  • CAGR
    CAGR (2021 - 2028)
    4.2%
  • Market Size 2021
    US$ 1 Billion
  • Market Size 2028
    US$ 1.33 Billion

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • Medtronic
  • Fresenius SE Co KGaA
  • Teleflex Incorporated
  • BD
  • Zimmer Biomet
  • Braile Biomedica
  • Haemonetics Corporation
  • SARSTEDT AG and Co KG
  • LivaNova PLC

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market SegmentType
  • Product and Accessories
Market SegmentApplication
  • Cardiac Surgeries
  • Orthopedic Surgeries
  • Organ Transplantation
  • Trauma Procedures
Market SegmentEnd User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Similarly, Canada has 22.2 donors per million population and is steadily improving, partially attributed to the figure of "Donation Physicians" - intensive care doctors who are responsible for organ donation. According to the World Transplant Registry, China had 5,818 donors in 2019, or 4.1 per million population and India had 715 donors or 0.5 per million population in 2019. On the other hand, Russia had a slightly higher rate of 5.1 donors per million people. The public-private partnership in collaboration with transplant coordinators has made a significant contribution to the improvement of organ transplantation. Both developing and developed countries have seen an increase in organ transplant surgeries. For example, developing countries such as India and Singapore are emerging as medical tourism destinations in Asia Pacific. Countries are progressing in terms of providing better and advanced medical treatments. Thus, the rising need for organ transplantation is among the key factors driving the demand for transplant diagnostics such as autotransfusion devices.

The autotransfusion process involves the reinfusion of the patient's blood. Blood is collected from the peritoneal cavity or thorax region. The process can be carried out before surgery or during and after the surgery using the autotransfusion system. Medical procedures, like joint replacement, spinal surgeries, and cardiac, among others, require autotransfusion. It helps to reduce the risk of infection, and also it eliminates the problems and complications associated with the banking and administration of homologous donor blood. It helps to prevent the transmission of transfusion-related blood-borne diseases in patients.

Market Insights
Technological Developments in Autotransfusion Devices

Autotransfusion devices are usually deployed during long-hour surgeries, such as kidney transplantation, and in cases of emergencies. These surgeries are associated with the chances of excessive blood loss, which makes it difficult to make up the blood loss with new blood, especially in case of rare blood groups. Owing to the ample demand, the key players in the autotransfusion devices market offer advanced and fully automated autotransfusion devices that reduce human interventions. For instance, in April 2021, LivaNova PLC's B-Capta has been approved by the US Food and Drug Administration. During complex paediatric and adult cardiopulmonary bypass surgeries, this device aids in the rapid and accurate monitoring of venous and blood gas parameters. Similarly, in April 2019, BD launched their BD BACTEC quality control media worldwide to help identify contaminated platelet units during transfusions.

Moreover, many companies employed strategic activities such as acquisitions, partnership and others to capture the market. For instance, Medtronics acquired AV Medical Technologies, in October 2019. In December 2019, Getinge purchased Applikon Biotechnology, a global leader in the development and supply of innovative bioreactor systems from the laboratory to the industrial scale. Thus, such advancements are likely to bring new trends in the autotransfusion devices market in the coming years.

Application–Based Insights

Based on application, the autotransfusion devices market is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest share of the market in 2021, while the organ transplantation segment is also estimated to register the highest CAGR in the market during the forecast period.

The autotransfusion devices market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio globally and meet the growing demand. The developments by the companies in the autotransfusion devices market have been characterized as organic and inorganic developments. Various companies are focusing on organic strategies, such as product launch and expansion. Inorganic growth strategies witnessed in the autotransfusion devices market were partnerships and collaborations. These growth strategies have aided the autotransfusion devices market players in the expansion of their businesses and enhanced their geographic presence. Additionally, growth strategies such as acquisitions and partnerships helped in strengthening their customer base and increasing the product portfolio. The companies have maximized their growth with several inorganic strategies to enhance the autotransfusion devices market value and position in the autotransfusion devices market. Organic developments hold 66.67% of the total strategic developments in the autotransfusion devices market. Whereas inorganic strategies account for 33.33% of the growth of the companies.

The autotransfusion devices market has been segmented as follows:

The autotransfusion devices market is segmented based on type, application, and end user. Based on type, the autotransfusion devices market is bifurcated into products and accessories. The autotransfusion devices market, based on application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others.

The autotransfusion devices market, based on end user, is divided into hospitals, specialty clinics, and ambulatory surgical centers.

Autotransfusion Devices Market Report Scope

Report Attribute Details
Market size in 2021 US$ 1 Billion
Market Size by 2028 US$ 1.33 Billion
Global CAGR (2021 - 2028) 4.2%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Product and Accessories
By Application
  • Cardiac Surgeries
  • Orthopedic Surgeries
  • Organ Transplantation
  • Trauma Procedures
By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic
  • Fresenius SE Co KGaA
  • Teleflex Incorporated
  • BD
  • Zimmer Biomet
  • Braile Biomedica
  • Haemonetics Corporation
  • SARSTEDT AG and Co KG
  • LivaNova PLC
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Company Profiles in Autotransfusion Devices Market

  • BD
  • Braile Biomedica
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic
  • Redax S.p.A.
  • SARSTEDT AG and Co. KG
  • Teleflex Incorporated
  • Zimmer Biomet
Report Coverage

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Segment Covered

Type, Application, End User

Regional Scope

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


Who are the key players in the autotransfusion devices market?

The autotransfusion devices market majorly consists of the players such as Medtronic; Fresenius SE & Co. KGaA; Teleflex Incorporated; BD; Zimmer Biomet; Braile Biomedica; Haemonetics Corporation; SARSTEDT AG and Co. KG; LivaNova PLC; Redax S.p.A. among others.

What is the regional market scenario of autotransfusion devices?

Global autotransfusion devices market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for autotransfusion devices. The US is estimated to hold the largest share in the autotransfusion devices market during the forecast period. The growth of the market is attributed to factors such as increasing prevalence of cancer in the US, and cancer awareness initiatives undertaken by local governments and global health organizations. In addition, growth involvement of rare blood groups, rising number of transplant procedures and rising prevalence of chronic diseases in the region stimulate the growth of autotransfusion devices market in North America. On the other hand, need for reinfusion of blood, and advancements in healthcare facilities and infrastructure in the Asia Pacific are expected to account for the fastest growth of the region during the coming years.

Which end-user held the largest share in the autotransfusion devices market?

The ambulatory surgery centers segment dominated the global autotransfusion devices market and accounted for the largest revenue share of 30.12% in 2021.

Which application held the largest share in the autotransfusion devices market?

The organ transplantation segment dominated the global autotransfusion devices market and held the largest revenue share of 3.22% in 2021.

Which type led the autotransfusion devices market?

The accessories segment dominated the global autotransfusion devices market and held the largest revenue share of 55.66% in 2021.

Which product led the autotransfusion devices market?

The intraoperative autotransfusion systems segment dominated the global autotransfusion devices market and held the largest revenue share of 71.70% in 2021

What are the driving factors for the autotransfusion devices market across the globe?

Key factors that are driving the growth of this market are rapid increase in chronic diseases, rise in transplant, and difficulty in obtaining blood of rare groups.

What are autotransfusion devices?

The autotransfusion process involves the reinfusion of the patient's blood collected from the peritoneal cavity or thorax region. The process can be accomplished before surgery or during and after the surgery using the autotransfusion system. Medical procedures, such as joint replacement, spinal surgeries, and cardiac surgery require autotransfusion. It helps reduce the risk of infection, and abolishes the problems and complications associated with the banking and administration of homologous donor blood. It also prevents transmission of transfusion-related blood-borne diseases in patients.

The List of Companies - Autotransfusion Devices Market

  1. Medtronic
  2. Fresenius SE & Co. KGaA
  3. Teleflex Incorporated
  4. BD
  5. Zimmer Biomet
  6. Braile Biomedica
  7. Haemonetics Corporation
  8. SARSTEDT AG and Co. KG
  9. LivaNova PLC
  10. Redax S.p.A.

Trends and growth analysis reports related to Medical Device : READ MORE..